Device's design and clinical perspectives for resistant hypertension therapy.
| Autor: | Jami O; Mohammed V University in Rabat, High School of Technology in Salé; Materials, Energy and Acoustics Team, Rabat, Morocco.; Mohammed VI University of Health Sciences, Biomedical Engineering Department, Casablanca, Morocco., Oussama EA; National High School of Arts and Crafts of Casablanca, Hassan II University of Casablanca, Morocco., Mohammed Z; Mohammed VI University of Health Sciences, Biomedical Engineering Department, Casablanca, Morocco., Soulaymane I; Mohammed VI University of Health Sciences, Biomedical Engineering Department, Casablanca, Morocco., Ilhaam BS; Mohammed VI University of Health Sciences, Faculty of Medicine, Casablanca, Morocco., Tijani Y; Mohammed VI University of Health Sciences, Faculty of Medicine, Casablanca, Morocco., Aziz E; Mohammed V University in Rabat, High School of Technology in Salé; Materials, Energy and Acoustics Team, Rabat, Morocco. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of cardiology. Cardiovascular risk and prevention [Int J Cardiol Cardiovasc Risk Prev] 2024 Jan 23; Vol. 20, pp. 200240. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2024). |
| DOI: | 10.1016/j.ijcrp.2024.200240 |
| Abstrakt: | Introduction: Hypertension is the leading cause of death in the cardiovascular system. Indeed, untreated hypertension can affect one's general health, but medicine can help hypertensive people reduce their chance of developing high blood pressure. However, secondary hypertension remains an unresolved illness. Areas Covered: This review will go through the typical and unusual device-based therapies for resistant hypertension that have arisen in recent years. Further to that, the innovations developed in device-based RH treatment will be covered, as well as the research and studies assessing these novel technologies. Expert Opinion: The innovative device-based techniques that target resistant hypertension provide a potential therapy that has been backed by a number of studies and clinical trials, whereas pharmacological non-adherence and increased sympathetic activity are recognized to be the primary causes of resistant hypertension. Nevertheless, some limitations will be critical for the future of these RH systems, with the device's design and larger RCTs playing a significant role in determining whether a position in routine treatment could be warranted. (© 2024 The Authors.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|